1. Home
  2. GPOR vs MIRM Comparison

GPOR vs MIRM Comparison

Compare GPOR & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gulfport Energy Corporation

GPOR

Gulfport Energy Corporation

HOLD

Current Price

$207.85

Market Cap

4.1B

Sector

Energy

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$79.34

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPOR
MIRM
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GPOR
MIRM
Price
$207.85
$79.34
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$229.78
$92.45
AVG Volume (30 Days)
218.6K
809.5K
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,231,668,000.00
$471,794,000.00
Revenue This Year
$57.83
$53.78
Revenue Next Year
$9.48
$19.91
P/E Ratio
N/A
N/A
Revenue Growth
38.91
53.66
52 Week Low
$153.27
$36.88
52 Week High
$225.78
$82.58

Technical Indicators

Market Signals
Indicator
GPOR
MIRM
Relative Strength Index (RSI) 51.01 62.33
Support Level $198.83 $77.99
Resistance Level $217.17 $82.58
Average True Range (ATR) 4.29 3.21
MACD 0.25 1.03
Stochastic Oscillator 49.62 83.25

Price Performance

Historical Comparison
GPOR
MIRM

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: